15 Jun '11
Australian Solagran’s subsidiary Solagran Sun has announced plans to invest $50m building a plant to produce pharmaceuticals from fir needles in Tomsk region.
The plant is reportedly to be built on a 2.4-hectare land site in the Southern field of the Tomsk special economic zone (SEZ).
Under plans, the complex is to make products to be used in pharmaceutical industry for production of medicine to treat cancer, gastrointestinal tract and liver diseases, and potentially – in pharmaceutical-cosmetics industry and agriculture.
The plant’s monthly capacity is 250 kilograms of polyprene.
Production is scheduled to be launched in 2014.